| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $106,301,785 ) (Continued on the next page) |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 Beverly Blvd. | Los Angeles | CA | 90048-1804 | LOS ANGELES | USA | CE146456 | Community Project Funding/Congressionally Directed Spending - Construction | 00 | 1 | HRSA | 7/29/2022 | $1,000,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA258204 | Targeting inhibitor-resistant breast tumors with HER3-homing nano-capsids | 000 | 1 | NIH | 5/9/2022 | $372,817 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K01AG076865 | Developing and Testing a Population Health Approach to Deprescribing and Optimizing Medications in Older Adults | 000 | 1 | NIH | 5/18/2022 | $124,854 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA270324 | Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases | 000 | 1 | NIH | 4/15/2022 | $382,013 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA259058 | Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci | 000 | 1 | NIH | 8/16/2022 | $668,422 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA268055 | NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer | 000 | 1 | NIH | 7/8/2022 | $518,399 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AG055865 | Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina | 001 | 5 | NIH | 5/4/2022 | $30,669 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AG055865 | Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina | 000 | 5 | NIH | 1/27/2022 | $276,021 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA244569 | Characterizing non-coding somatic and germline variant interactions in ovarian cancer | 000 | 3 | NIH | 5/26/2022 | $663,739 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA151610 | The Role of FOXCI in Basal-like Breast Cancer | 001 | 10 | NIH | 5/24/2022 | $33,251 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA151610 | The Role of FOXCI in Basal-like Breast Cancer | 000 | 10 | NIH | 12/23/2021 | $374,062 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL143227 | Mediators of Systemic Inflammation and Heart Failure Risk in the Community | 000 | 4 | NIH | 4/12/2022 | $727,863 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA218133 | Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer | 000 | 5 | NIH | 8/16/2022 | $451,870 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01EB028146 | Motion-Resolved, Comprehensive Quantitative Tissue Characterization Using MR Multitasking | 001 | 4 | NIH | 6/27/2022 | $62,857 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01EB028146 | Motion-Resolved, Comprehensive Quantitative Tissue Characterization Using MR Multitasking | 000 | 4 | NIH | 1/24/2022 | $565,718 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL143227 | Mediators of Systemic Inflammation and Heart Failure Risk in the Community | 001 | 4 | NIH | 6/8/2022 | $80,876 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01DK118265 | Understanding Epithelial Plasticity in Renal Repair after Acute Kidney Injury | 000 | 5 | NIH | 6/22/2022 | $382,389 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AI103542 | Role of Blimp1 (Prdm1) in lung immune responses and tolerance | 000 | 8 | NIH | 6/9/2022 | $505,484 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01AG078655 | ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis | 000 | 1 | NIH | 7/27/2022 | $544,545 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K08HL141446 | The role of type 1 interferon in regulating alloimmune responses to transfused red blood cells | 000 | 5 | NIH | 6/3/2022 | $164,052 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01AI164504 | Sex and gender differences in lupus - intersection between immunometabolism, epigenetic remodeling and cardiac involvement | 000 | 2 | NIH | 7/27/2022 | $582,543 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | F31HL154777 | Characterization of pulmonary progenitor cell dysfunction in COPA syndrome | 000 | 3 | NIH | 8/15/2022 | $38,948 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K08CA259456 | Targeting the Stroma for Pancreatic Cancer Treatment | 000 | 3 | NIH | 4/7/2022 | $244,172 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01DK123446 | Role of microbiota, host genetics and mesenteric adipose in Crohn's disease fibrosis and post-op recurrence. | 000 | 3 | NIH | 1/11/2022 | $344,250 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01DK123446 | Role of microbiota, host genetics and mesenteric adipose in Crohn's disease fibrosis and post-op recurrence. | 001 | 3 | NIH | 3/25/2022 | $38,250 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HD106096 | Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health | 000 | 2 | NIH | 7/21/2022 | $735,395 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 004 | 3 | NIH | 7/11/2022 | $0 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 003 | 3 | NIH | 7/6/2022 | $144,870 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 002 | 3 | NIH | 2/21/2022 | $123,849 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 001 | 3 | NIH | 1/28/2022 | $1,629,789 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K08CA245483 | Decoupling Bidirectional EphB/ephrinB2 in Multiple Myeloma | 000 | 3 | NIH | 4/19/2022 | $256,859 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL142579 | Macrophages as effectors of cell therapy for heart failure | 001 | 4 | NIH | 6/18/2022 | $42,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL142579 | Macrophages as effectors of cell therapy for heart failure | 000 | 4 | NIH | 2/9/2022 | $382,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL159953 | Syndecan-1 suppression of lung inflammation | 000 | 1 | NIH | 4/25/2022 | $600,248 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL160908 | The role of GATA3-positive macrophages in cardiovascular pathologies | 000 | 1 | NIH | 6/13/2022 | $417,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA266544 | Spatially resolved, single cell biomarkers of B cell lymphoma | 000 | 1 | NIH | 7/15/2022 | $616,249 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL164983 | Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI | 000 | 1 | NIH | 6/13/2022 | $834,798 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL165471 | Mechanisms of sex-biased risk and resiliency in aneurysm and dissection | 000 | 1 | NIH | 9/16/2022 | $407,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL165471 | Mechanisms of sex-biased risk and resiliency in aneurysm and dissection | 000 | 1 | NIH | 9/16/2022 | $10,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01DK080834 | Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut InducesDiarrhea | 004 | 16 | NIH | 6/23/2022 | $375,451 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA075115 | Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression | 002 | 23 | NIH | 7/19/2022 | $405,059 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL159160 | Basal cells in airway and alveolar remodeling | 000 | 1 | NIH | 4/28/2022 | $604,959 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA267108 | Sexual Dimorphism in Bladder Cancer | 000 | 1 | NIH | 8/1/2022 | $577,209 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL165169 | Autoantibody-induced type 1 interferons and RBC alloimmunization in sickle cell disease | 000 | 1 | NIH | 6/10/2022 | $417,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01DK131071 | FGFR Signaling in Liver Injury and Fibrosis | 000 | 1 | NIH | 6/7/2022 | $438,059 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL153500 | Myocardial Steatosis in Women with Coronary Microvascular Dysfunction: Defining the Pathway to Heart Failure with Preserved Ejection Fraction (HFpEF) | 000 | 2 | NIH | 7/14/2022 | $640,618 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R21CA256421 | Neoadjuvant anti-PD-1 immunotherapy and Stereotactic Radiation in Patients with Recurrent Glioblastoma | 000 | 1 | NIH | 12/8/2021 | $195,181 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA252211 | Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | 000 | 2 | NIH | 5/3/2022 | $680,220 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL146158 | Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF) | 001 | 4 | NIH | 6/6/2022 | $438,723 |
|
